DaVita [DVA] vs Ensign Group [ENSG] Detailed Stock Comparison
DaVita
NYSE
Loading...
Ensign Group
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: DaVita wins in 13 metrics, Ensign Group wins in 6 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | DaVita | Ensign Group | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.45 | 30.10 | DaVita |
| Price-to-Book Ratio | 6.68 | 4.72 | Ensign Group |
| Debt-to-Equity Ratio | 825.19 | 100.93 | Ensign Group |
| PEG Ratio | 5.74 | 1.72 | Ensign Group |
| EV/EBITDA | 8.84 | 22.74 | DaVita |
| Profit Margin (TTM) | 6.35% | 7.00% | Ensign Group |
| Operating Margin (TTM) | 15.70% | 8.46% | DaVita |
| EBITDA Margin (TTM) | 15.70% | 8.46% | DaVita |
| Return on Equity | 57.94% | 17.54% | DaVita |
| Return on Assets (TTM) | 7.15% | 5.30% | DaVita |
| Free Cash Flow (TTM) | $1.47B | $188.95M | DaVita |
| Dividend Yield | N/A | 0.20% | N/A |
| 1-Year Return | -10.66% | 14.30% | Ensign Group |
| Price-to-Sales Ratio (TTM) | 0.74 | 2.08 | DaVita |
| Enterprise Value | $23.77B | $11.14B | DaVita |
| EV/Revenue Ratio | 1.81 | 2.42 | DaVita |
| Gross Profit Margin (TTM) | 33.08% | 16.19% | DaVita |
| Revenue per Share (TTM) | $164 | $81 | DaVita |
| Earnings per Share (Diluted) | $10.16 | $5.52 | DaVita |
| Beta (Stock Volatility) | 1.09 | 1.02 | Ensign Group |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
DaVita vs Ensign Group Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| DaVita | 0.12% | 2.37% | -1.33% | -2.32% | -3.38% | -8.17% |
| Ensign Group | 0.14% | 1.95% | 23.24% | 15.87% | 33.96% | 27.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| DaVita | -10.66% | 55.19% | 58.25% | 80.34% | 320.48% | 517.78% |
| Ensign Group | 14.30% | 94.69% | 188.61% | 666.49% | 3,703.15% | 4,007.77% |
Performance & Financial Health Analysis: DaVita vs Ensign Group
| Metric | DVA | ENSG |
|---|---|---|
| Market Information | ||
| Market Cap | $9.77B | $9.59B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,051,160 | 413,600 |
| 90 Day Avg. Volume | 841,127 | 444,053 |
| Last Close | $137.58 | $169.24 |
| 52 Week Range | $126.07 - $179.60 | $118.73 - $170.37 |
| % from 52W High | -23.40% | -0.66% |
| All-Time High | $179.60 (Jan 27, 2025) | $170.37 (Aug 21, 2025) |
| % from All-Time High | -23.40% | -0.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.19% |
| Quarterly Earnings Growth | -0.11% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.07% |
| Operating Margin (TTM) | 0.16% | 0.08% |
| Return on Equity (TTM) | 0.58% | 0.18% |
| Debt to Equity (MRQ) | 825.19 | 100.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-4.98 | $35.23 |
| Cash per Share (MRQ) | $10.34 | $7.30 |
| Operating Cash Flow (TTM) | $1.86B | $462.89M |
| Levered Free Cash Flow (TTM) | $1.10B | $30.01M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.20% |
| Last 12-Month Dividend | N/A | $0.30 |
Valuation & Enterprise Metrics Analysis: DaVita vs Ensign Group
| Metric | DVA | ENSG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.45 | 30.10 |
| Forward P/E | 12.13 | 27.06 |
| PEG Ratio | 5.74 | 1.72 |
| Price to Sales (TTM) | 0.74 | 2.08 |
| Price to Book (MRQ) | 6.68 | 4.72 |
| Market Capitalization | ||
| Market Capitalization | $9.77B | $9.59B |
| Enterprise Value | $23.77B | $11.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.81 | 2.42 |
| Enterprise to EBITDA | 8.84 | 22.74 |
| Risk & Other Metrics | ||
| Beta | 1.09 | 1.02 |
| Book Value per Share (MRQ) | $-4.98 | $35.23 |
Financial Statements Comparison: DaVita vs Ensign Group
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DVA | ENSG |
|---|---|---|
| Revenue/Sales | $3.22B | $1.23B |
| Cost of Goods Sold | $2.24B | $1.03B |
| Gross Profit | $983.87M | $198.79M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $433.33M | $103.90M |
| EBITDA | $597.84M | $140.17M |
| Pre-Tax Income | $286.33M | $112.36M |
| Income Tax | $54.12M | $27.89M |
| Net Income (Profit) | $232.22M | $84.47M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DVA | ENSG |
|---|---|---|
| Cash & Equivalents | $438.78M | $282.67M |
| Total Current Assets | $3.64B | $986.39M |
| Total Current Liabilities | $2.91B | $705.21M |
| Long-Term Debt | $11.72B | $1.91B |
| Total Shareholders Equity | $1.66B | $1.93B |
| Retained Earnings | $1.70B | $1.50B |
| Property, Plant & Equipment | $11.65B | $2.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DVA | ENSG |
|---|---|---|
| Operating Cash Flow | $287.94M | $97.90M |
| Capital Expenditures | $-143.26M | $-42.93M |
| Free Cash Flow | $36.75M | $29.29M |
| Debt Repayment | $-345.97M | $-1.01M |
| Common Stock Repurchase | $-541.85M | $-10.79M |
Short Interest & Institutional Ownership Analysis
| Metric | DVA | ENSG |
|---|---|---|
| Shares Short | 6.11M | 1.73M |
| Short Ratio | 8.22 | 3.98 |
| Short % of Float | 0.16% | 0.04% |
| Average Daily Volume (10 Day) | 1,051,160 | 413,600 |
| Average Daily Volume (90 Day) | 841,127 | 444,053 |
| Shares Outstanding | 80.54M | 57.44M |
| Float Shares | 35.70M | 55.24M |
| % Held by Insiders | 0.50% | 0.03% |
| % Held by Institutions | 0.52% | 0.95% |
Dividend Analysis & Yield Comparison: DaVita vs Ensign Group
| Metric | DVA | ENSG |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.30 |
| Last 12-Month Dividend Yield | N/A | 0.20% |
| 3-Year Avg Annual Dividend | N/A | $0.26 |
| 3-Year Avg Dividend Yield | N/A | 0.05% |
| 3-Year Total Dividends | N/A | $0.78 |
| Ex-Dividend Date | N/A | Jun 30, 2025 |